Back
Nektar Therapeutics Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
37
NKTR
Nektar Therapeutics
Last Price:
$0.71
Seasonality Move:
-4.36%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.68 | Sell |
| 20-day SMA: | 0.68 | Sell |
| 50-day SMA: | 0.73 | Sell |
| 200-day SMA: | 1.03 | Sell |
| 8-day EMA: | 0.65 | Sell |
| 20-day EMA: | 0.68 | Sell |
| 50-day EMA: | 0.73 | Sell |
| 200-day EMA: | 0.94 | Sell |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 39.02 | Sell |
| Chaikin Money Flow: | -1021170 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.55 - 0.73) | Sell |
| Bollinger Bands (100): | (0.67 - 0.97) | Sell |
Nektar Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.59 while NKTR 8-day simple moving average is 0.68, which is a Sell signal.
-
The stock price of NKTR is 0.59 while Nektar Therapeutics 20-day SMA is 0.68, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 0.73 while NKTR share price is 0.59, making it a Sell technically.
-
NKTR stock price is 0.59 and Nektar Therapeutics 200-day simple moving average is 1.03, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
37
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $0.59. The Score for NKTR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
109.6M
Price in USD:
0.59
Share Volume:
1.9M
Nektar Therapeutics 52-Week Range
52-Week High:
1.93
52-Week Low:
0.43
Sell
37
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 0.59 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.59 while NKTR 8-day exponential moving average is 0.65, which is a Sell signal.
-
The stock price of NKTR is 0.59 while Nektar Therapeutics 20-day EMA is 0.68, which makes it a Sell.
-
Nektar Therapeutics 50-day exponential moving average is 0.73 while NKTR share price is 0.59, making it a Sell technically.
-
NKTR stock price is 0.59 and Nektar Therapeutics 200-day simple moving average is 0.94, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.07 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 39.02, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is (0.55 - 0.73), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (0.67 - 0.97), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.